Analysts Anticipate GNC Holdings Inc (GNC) to Announce $0.33 EPS

Merck's Keytruda continued to swipe share from Bristol's immuno-oncology drugs but Bristol is

Merck's Keytruda continued to swipe share from Bristol's immuno-oncology drugs but Bristol is"holding up better than expected

According to analysts minimum EPS for the current quarter is expected at $0.21 and can go high up to $0.42. GNC's profit will be $22.44 million for 6.73 P/E if the $0.33 EPS becomes a reality. Revenues totaled $644.8 million in the first quarter of 2017, compared to revenues of $668.9 million a year ago. The company's 5 year Earnings per share growth and Capital Spending growth remains at 0 and 6.34.

The analysts offering 12 month price targets for GNC Holdings, Inc. have a median target of $6.25, with a high estimate of $20 and a low estimate of $4. Chicago-based equity research firm Zacks Investment Research has assigned this stock ABR (Average Brokerage Recommendation) of 3.63, suggesting the market has given up on the stock. GNC Holdings Inc (NYSE:GNC) has declined 65.07% since September 9, 2016 and is downtrending. Moreover, net income dropped by more than half, leaving the company with just $0.37 per share in adjusted earnings. The company had Year Ago Sales of 668.9 Million. The business's revenue for the quarter was down 7.8% on a year-over-year basis.

Since the earnings release, a slew of analysts reiterated their stock ratings with several analysts expressing more bearish opinions.

Revenue is the amount of money that a company actually receives during a specific period, including discounts and deductions for returned merchandise. Barclays PLC lowered GNC Holdings from an "equal weight" rating to an "underweight" rating and lowered their price objective for the company from $15.00 to $11.00 in a research report on Tuesday, December 13th. Five equities research analysts have rated the stock with a sell rating, eight have given a hold rating and one has given a buy rating to the stock. The new target price indicates a possible upside of 0.10% from the company's previous stock price.

The stock decreased 0.82% or $0.06 during the last trading session, hitting $7.30. A total of 26.61M shares exchanged hands, whereas the company's average trading volume stands at 4.38M shares. The stock's 52-week range is $6.51 - $35.90. The firm has a 50-day moving average of $7.39 and a 200 day moving average of $11.74.

The stock remained 3.65% volatile for the week and 4.45% for the month. California State Teachers Retirement accumulated 131,067 shares or 0% of the stock. Following the completion of the transaction, the senior vice president now directly owns 74,512 shares of the company's stock, valued at approximately $575,232.64. The disclosure for this purchase can be found here. The company has already started seeing transformational changes during the first quarter 2017. The market capitalization of the company is at $619.1 Million. Globeflex Capital L P boosted its position in shares of GNC Holdings by 76.7% in the second quarter.

Analysts' mean recommendation for GNC Holdings, Inc. BlackRock Group LTD boosted its position in shares of GNC Holdings by 2.0% in the second quarter. GNC Holdings comprises approximately 2.6% of Shah Capital Management's investment portfolio, making the stock its 11th largest position. Finally, Tudor Investment Corp Et Al raised its stake in shares of GNC Holdings by 10.7% in the fourth quarter.

Investors sentiment increased to 1.21 in 2016 Q4.

GNC Holdings, a specialty retailer of health, wellness and performance products, including vitamins, minerals and herbal supplement products (VMHS), sports nutrition products and diet products.

GNC Holdings reports its operations under three segments: U.S. & Canada - including company-owned stores in the U.S., Puerto Rico and Canada, franchise stores in the U.S. and e-commerce; global - including franchise locations in approximately 50 countries, The Health Store and China operations; and Manufacturing/Wholesale - comprising manufactured product sold to other segments, third-party contract manufacturing and sales to wholesale partners.

Latest News